Pancreatic cancer vaccine shows promise in first human trial, preventing disease in high-risk patients - Fox News
Video New drug shows promise in fight against pancreatic cancer Fox News senior correspondent Jonathan Serrie reports on doctors seeing results from Daraxonrasib, a new drug targeting pancreatic cancer, on ‘Special Report.’ A new vaccine for the prevention of pancreatic cancer has shown promise in an early study at Johns Hopkins School of Medicine in Baltimore, Maryland. A phase 1 trial published in Cancer Discovery, a journal of the American Association for Cancer Research, tested an experimental vaccine called mKRAS-VAX in 20 people, according to a press release.